Compounds and methods

Details for Australian Patent Application No. 2011205283 (hide)

Owner Tempero Pharmaceuticals, Inc.

Inventors Baloglu, Erkan; Ghosh, Shomir; Lobera, Mercedes; Schmidt, Darby

Agent Davies Collison Cave

Pub. Number AU-A-2011205283

PCT Pub. Number WO2011/088181

Priority 61/294,575 13.01.10 US

Filing date 13 January 2011

Wipo publication date 21 July 2011

International Classifications

A61K 31/497

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/088181 Priority application(s): WO2011/088181

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205290-Use of an adrenal hormone-modifying agent

2011205282-Compositions and methods for minimizing nornicotine synthesis in tobacco